David T. Cooke, MD, Danh V. Nguyen, PhD, Ying Yang, MS, Steven L

Slides:

Advertisements

Similar presentations

Results of Initial Operations in Non–Small Cell Lung Cancer Patients With Single-Level N2 Disease Yasuhiko Ohta, MD, Yosuke Shimizu, MD, Hiroshi Minato,

Advertisements

Squamous Cell Carcinoma of the Pericardium Found During Coronary Bypass Surgery of Possible Cutaneous Origin Alan P. Kypson, MD, Curtis A. Anderson,

Elizabeth A. David, MD, David T

Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes Meng S. Shao, MD, Andrew T. Wong, MD,

Treating Constrictive Pericarditis in a Chinese Single-Center Study: A Five-Year Experience Yiyun Lin, MD, Mi Zhou, MMS, Jian Xiao, MD, Bin Wang, MD,

Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F

Comparison of Thoracoscopic Segmentectomy and Thoracoscopic Lobectomy for Small-Sized Stage IA Lung Cancer Chenxi Zhong, MD, Wentao Fang, MD, Teng Mao,

Rodrigo A. S. Sardenberg, MD, Clovis Pinto, MD, Cynthia A

Long-Term Outcomes After Isolated Aortic Valve Replacement in Octogenarians: A Modern Perspective Vinod H. Thourani, MD, Richard Myung, MD, Patrick Kilgo,

Jeevan Nagendran, MD, Colleen M. Norris, PhD, Michelle M

Collision Tumor of Esophagus: Report of Three Cases

Joshua E. Rosen, BASc, Hari B

Zhiqiang Xue, MD, Fengying Wu, MD, Karlyn E

Hancock II Bioprosthesis for Aortic Valve Replacement: The Gold Standard of Bioprosthetic Valves Durability? Tirone E. David, MD, Susan Armstrong, MS,

Elliot Wakeam, MD, MPH, Meredith Giuliani, MBBS, MEd, Natasha B

Nirav S. Kapadia, MD, MS, Luca F. Valle, MD, Julie A

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

Histologic Evolution From Adenocarcinoma to Squamous Cell Carcinoma After Gefitinib Treatment Min-Shu Hsieh, MD, Jie-Yang Jhuang, MD, Syue-Fong Hua,

Epidermal Growth Factor Receptor Is a Prognosis Predictor in Patients With Esophageal Squamous Cell Carcinoma Wencheng Zhang, MD, Hongxia Zhu, MD, Xiao.

Osteopontin Combined With CD44v6, a Novel Prognostic Biomarker in Non-Small Cell Lung Cancer Undergoing Curative Resection Bing-sheng Sun, MD, PhD, Yue.

Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases

Induction Chemotherapy is Not Superior to a Surgery-First Strategy for Clinical N1 Non- Small Cell Lung Cancer Paul J. Speicher, MD, Zachary W. Fitch,

Castigliano M. Bhamidipati, DO, MS, George J

Prognostic Variables in Thoracic Esophageal Squamous Cell Carcinoma

Wickii T. Vigneswaran, MD, Diana Y

Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer Robert E. Merritt, MD, Chuong D. Hoang, MD,

A Comparison of Length of Stay, Readmission Rate, and Facility Reimbursement After Lobectomy of the Lung Richard K. Freeman, MD, MBA, J. Russell Dilts,

Linda Henry, PhD, RN, Linda Halpin, MSN, RN, Sharon Hunt, MBA, Sari D

Nodular Lymphoid Hyperplasia of the Lung: A Very Rare Disease Entity

Lung Cancer Surgery in Patients With Liver Cirrhosis

Conditional Cancer-Specific Versus Cardiovascular-Specific Survival After Lobectomy for Stage I Non-Small Cell Lung Cancer Shawn S. Groth, MD, MS, Natasha.

Total Arterial Revascularization: A Superior Strategy for Diabetic Patients Who Require Coronary Surgery James Tatoulis, MD, FRACS, Rochelle Wynne, PhD,

Asad A. Shah, MD, Mathias Worni, MD, MHS, Christopher R

Primary Pulmonary Lymphoma

Impact of Lepidic Component Occupancy on Effects of Adjuvant Chemotherapy for Lung Adenocarcinoma Shinsuke Sasada, MD, PhD, Yoshihiro Miyata, MD, PhD,

Age-Dependent Gender Disparities in Post Lung Transplant Survival Among Patients With Idiopathic Pulmonary Fibrosis Shahid I. Sheikh, MD, Don Hayes,

Radical Lymph Node Dissection in Primary Esophagectomy for Esophageal Squamous Cell Carcinoma Chen-Sung Lin, MD, PhD, Chih-Tao Cheng, MD, DrPH, Chao-Yu.

Elliot Wakeam, MD, MPH, James P. Byrne, MD, Gail E

Impact of Blood Product Transfusion on Short and Long-Term Survival After Cardiac Surgery: More Evidence Balu Bhaskar, MD, FCICM, Joel Dulhunty, PhD,

Comparison of the 6th and 7th Editions of the American Joint Committee on Cancer Tumor-Node-Metastasis Staging System in Patients With Resected Esophageal.

Complete Resection of Oligorecurrence of Stage I Lung Adenocarcinoma 19 Years After Operation Dai Sonoda, MD, Masashi Mikubo, MD, Kazu Shiomi, MD, PhD,

Number of Lymph Nodes Associated With Maximal Reduction of Long-Term Mortality Risk in Pathologic Node-Negative Non–Small Cell Lung Cancer Raymond U.

Smoking Status as a Prognostic Factor in Patients with Stage I Pulmonary Adenocarcinoma Ichiro Yoshino, MD, PhD, Daigo Kawano, MD, Taro Oba, MD, Koji.

Andrew P. Dhanasopon, MD, Michelle C. Salazar, MD, Jessica R

Differences in Patterns of Recurrence in Early-Stage Versus Locally Advanced Non- Small Cell Lung Cancer Feiran Lou, MD, MS, Camelia S. Sima, MD, MS,

Surgical Therapy for Bilateral Multiple Primary Lung Cancer

Kathryn E. Engelhardt, MD, Malcolm M. DeCamp, MD, Anthony D

Eric S. Weiss, MD, MPH, Jeremiah G. Allen, MD, Christian A

High Expression of p300 Has an Unfavorable Impact on Survival in Resectable Esophageal Squamous Cell Carcinoma Yong Li, MD, Hao-Xian Yang, MD, Rong-Zhen.

Sublobar Resection Provides an Equivalent Survival After Lobectomy in Elderly Patients With Early Lung Cancer Jiro Okami, MD, PhD, Yuri Ito, PhD, Masahiko.

Characteristics of Malignant Pleural Mesothelioma in Women

Clinicopathologic Features and Computed Tomographic Findings of 52 Surgically Resected Adenosquamous Carcinomas of the Lung Yukio Watanabe, MD, Koji.

A Strategy for Determining Which Thoracic Esophageal Cancer Patients Should Undergo Cervical Lymph Node Dissection Shiro Nagatani, MD, Yutaka Shimada,

Prognostic Significance of Aberrant Methylation of Solute Carrier Gene Family 5A8 in Lung Adenocarcinoma Koei Ikeda, MD, PhD, Kenji Shiraishi, MD, PhD,

Adhering to Quality Measures in Esophagectomy Is Associated With Improved Survival in All Stages of Esophageal Cancer Pamela Samson, MD, MPHS, Varun.

Complex Cusp Repair in Patients Undergoing the David Procedure: Is It Worth It? Hardy Baumbach, MD, Kristina Wachter, MD, Ragi Nagib, MD, Samir Ahad,

Resected Synchronous Primary Malignant Lung Tumors: A Population-Based Study Hans Rostad, MD, PhD, Trond-Eirik Strand, MD, Anne Naalsund, MD, Jarle Norstein,

Prolonged Intensive Care Unit Stay in Cardiac Surgery: Risk Factors and Long-Term- Survival Ortrud Vargas Hein, MD, Jürgen Birnbaum, MD, Klaus Wernecke,

Treatment Outcomes of Patients With Different Subtypes of Large Cell Carcinoma of the Lung Yung-Han Sun, MS, Shih-Wei Lin, PhD, Chih-Cheng Hsieh, MD,

Neal S Goldstein, MD The Annals of Thoracic Surgery

Steve K. Singh, MD, Gilbert H. L. Tang, MD, Manjula D

Effect of Formalin Fixation on Tumor Size Determination in Stage I Non-Small Cell Lung Cancer Po-Kuei Hsu, MD, Hsu-Chih Huang, MD, Chih-Cheng Hsieh,

Results of Initial Operations in Non–Small Cell Lung Cancer Patients With Single-Level N2 Disease Yasuhiko Ohta, MD, Yosuke Shimizu, MD, Hiroshi Minato,

Clinical Outcome After Pulmonary Resection for Lung Cancer Patients on Hemodialysis Toshiro Obuchi, MD, Wakako Hamanaka, MD, Yasuhiro Yoshida, MD, Jun.

Survival and Outcomes of Pulmonary Resection for Non-Small Cell Lung Cancer in the Elderly: A Nested Case-Control Study Robert J. Cerfolio, MD, Ayesha.

Mark I. Block, MD The Annals of Thoracic Surgery

Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD

Early Surgical Results After Pneumonectomy for Non-Small Cell Lung Cancer are not Affected by Preoperative Radiotherapy and Chemotherapy Tomas Gudbjartsson,

Long-Term Results of Sleeve Lobectomy in the Management of Non–Small Cell Lung Carcinoma and Low-Grade Neoplasms Robert E. Merritt, MD, Douglas J. Mathisen,

Kathleen E. Simpson, MD, Elizabeth Pruitt, MSPH, James K

Presentation transcript:

Survival Comparison of Adenosquamous, Squamous Cell, and Adenocarcinoma of the Lung After Lobectomy David T. Cooke, MD, Danh V. Nguyen, PhD, Ying Yang, MS, Steven L. Chen, MD, MBA, Cindy Yu, MD, Royce F. Calhoun, MD The Annals of Thoracic Surgery Volume 90, Issue 3, Pages 943-948 (September 2010) DOI: 10.1016/j.athoracsur.2010.05.025 Copyright © 2010 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 (A) In this high-power photomicrograph of (A) an adenosquamous carcinoma of the lung, squamous component is identified at the right lower half of the picture, and glandular adenocarcinoma component is at the left upper half. High-power micrographs show (B) a well-differentiated adenocarcinoma and a (C) moderately differentiated squamous cell carcinoma of the lung. (Hematoxylin and eosin stain; for (A, B, C) magnification ×10.) The Annals of Thoracic Surgery 2010 90, 943-948DOI: (10.1016/j.athoracsur.2010.05.025) Copyright © 2010 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Kaplan-Meier survival curves are shown for patients based on (A) combined early-stage, (B) stage I, and (C) stage II adenocarcinoma, squamous cell, and adenosquamous after lobectomy. (CI = confidence interval.) The Annals of Thoracic Surgery 2010 90, 943-948DOI: (10.1016/j.athoracsur.2010.05.025) Copyright © 2010 The Society of Thoracic Surgeons Terms and Conditions